Germany’s healthcare system is praised as one of the best in the world. In this article, we review Germany’s health system by critically analysing its structure, funding, resource allocation, provider payments, efficiency, health outcomes, and access. Whilst health provision and access are...

A project aimed at presenting initial results from the implementation of the System of Health Accounts has been carried by the Health Policy Unit at the OECD and experts from thirteen member countries. The results are presented in the form of a comparative study (OECD Health Working Papers No....

During the next decades the populations of most developed countries will grow older as a result of the low level of birth rates since the 1970s and/or the continuously increasing life expectancy. We show within a Generational Accounting framework how unsustainable the public finances of France,...

Background: Traditionally in Germany all new drugs were automatically reimbursed by Social Health Insurance. This practice is seen increasingly critically. A new public institute was founded to examine the benefits of new medicines. The peoples' views on the benefits of new drugs and on which...

This paper describes pharmaceutical pricing and reimbursement policies in Germany, considering them in the broader environment in which they operate, and assesses their impact on the achievement of a number of policy goals. Pharmaceutical coverage is comprehensive, with a high level of public...

This paper investigates competition between health insurance companies under different financing regulations. We consider two alternatives advanced in recent German health care reform discussions: competition by contribution rates (health contributions) and by fees (health premia). We find that...

This paper investigates competition between health insurance companies under different financing regulations. We consider two alternatives advanced in recent German health care reform discussions: competition by contribution rates (health contributions) and by fees (health premia). We find that...